James C Meyer, DO Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 800 Kenyon Rd, Fort Dodge, IA 50501 Phone: 515-574-6845 |
James Matthew Wilson, M.D. Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 802 Kenyon Rd, Fort Dodge, IA 50501 Phone: 515-573-3101 |
Elizabeth Day, DO Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 800 Kenyon Rd, Fort Dodge, IA 50501 Phone: 515-574-6845 |
News Archive
Amgen Inc. today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter for the Biologic License Applications (BLA) for Prolia(TM) (denosumab) in the treatment and prevention of postmenopausal osteoporosis.
For decades, dermatologists have been researching the genetic cause of aging skin so that the perfect antidote could be developed. When examining genes and proteins, a difference between younger and older looking skin has not been found.
On average, children take the first steps on their own at the age of 12 months. Many parents perceive this event as a decisive turning point. However, the timing is really of no consequence. Children who start walking early turn out later to be neither more intelligent nor more well-coordinated.
Pfizer Inc. announced today that the European Medicines Agency (EMA) has accepted Pfizer's regulatory submissions for review of two investigational compounds - crizotinib, an oral first-in-class anaplastic lymphoma kinase (ALK) inhibitor, for the treatment of patients with previously treated ALK-positive advanced non-small cell lung cancer (NSCLC); and bosutinib for the treatment of adult patients with newly diagnosed Philadelphia chromosome positive (Ph+) chronic myeloid leukemia (CML) in the chronic phase.
› Verified 8 days ago